Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Artificial Iris Market: By Type, By Age Group, By Application, By End-user and Geography
Artificial Iris Market size was valued at US$ 16.5 million in 2023 and is poised to grow at a significant CAGR of 9.7% from 2024-2030. The natural pupil regulates how much light enters the eye, and those with abnormalities of the pupil or iris may see glare or haloes in intense natural or artificial light. Patients may also want to have their abnormally dilated pupils treated because they are self-conscious about their appearance. Artificial Iris has evolved as a solution to these problems. The rise in the geriatric population, age-related eye abnormalities, and rising demand for minimally invasive surgical treatments may all be factors driving the adoption of the artificial iris.
The United Nations defines population aging as a demographic shift resulting in a higher proportion of older adults. While population aging is speeding up, growth is slowing in some regions and nations. Around 962 million people, or 13% of the world's population, were predicted to be 60 or older as of 2017. An estimated 3% of the population turns 60 or older each year. Other sections of the world will also experience rapid aging, and by 2050, every continent outside Africa will have a population of at least 25% older than 60. Furthermore, according to estimates, there will be 1.4 billion older people globally by 2030, 2.1 billion by 2050, and 3.1 billion by 2100.
Additionally, according to two extensive Scandinavian investigations, between 1 in 40,000 and 72,000 live newborns are found to have classical aniridia. Moreover, 1 in 2077 live births resulted in ocular coloboma. As a result, the market for artificial iris will continue to rise at a constant rate due to the expanding worldwide population, primarily composed of geriatric people who are more prone to eye illnesses. It is therefore anticipated that it will increase competition in the artificial iris sector.
In February 2020, Human Optics AG received health insurance approval for its artificial iris Customflex Artificial Iris in the United States.
Study Period
2024-2030Base Year
2023CAGR
9.7%Largest Market
Asia PacificFastest Growing Market
North America
Increased prevalence of eye conditions such as congenital aniridia, aesthetic concerns, and traumatic iris loss is the primary driver of the market's expansion. According to an NCBI article, aniridia is found in around 1.8/100,000 live births annually, with a global frequency ranging from 1:40,000 to 1:100,000. The primary driver of the worldwide artificial iris market is the increase in clinical trials targeted at developing cutting-edge technologies to treat various eye problems. The market is also being driven by recent regulatory approval for artificial iris implants and growing concerns about improving the cosmetic look of the eye. On the other hand, due to legal limitations for its use, the artificial iris is still a novel concept and is only authorized for use in a few nations. The expansion of the global market is also hampered by side effects related to implant procedures.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 16.5 million |
Market CAGR |
9.7% |
By Type |
|
By Age Group |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global artificial iris market size was valued at US$ 16.5 million in 2023 and is projected to grow at a significant CAGR of 9.7% from 2024-2030.
HumanOptics AG, Morcher GmbH, Ophtec BV, EyeYon Medical, Spectrum Surgical
North America is the fastest-growing region for artificial iris market
1. Executive Summary |
2. Global Artificial Iris Market Introduction |
2.1. Global Artificial Iris Market - Taxonomy |
2.2. Global Artificial Iris Market - Definitions |
2.2.1. Type |
2.2.2. Age Group |
2.2.3. Application |
2.2.4. End-user |
2.2.5. Region |
3. Global Artificial Iris Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Key Developments |
4. Global Artificial Iris Market By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
4.1. Fiber |
4.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.3. Market Opportunity Analysis |
4.2. Fiber Free |
4.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.3. Market Opportunity Analysis |
5. Global Artificial Iris Market By Age Group, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Pediatric |
5 1 1 Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Adult |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Artificial Iris Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Therapeutic |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Cosmetic |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Artificial Iris Market By End-user , 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Public Hospitals |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Private Hospitals |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Global Artificial Iris Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. RoW |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.6. Global Artificial Iris Market - Opportunity Analysis Index, By Age Group, Type, Application, End-user , and Region, 2024-2030 |
9. North America Artificial Iris Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Fiber |
9.1.2. Fiber Free |
9.2. Age Group Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Pediatric |
9.2.2. Adult |
9.3. Application Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Therapeutic |
9.3.2. Cosmetic |
9.4. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1. Public Hospitals |
9.4.2. Private Hospitals |
9.5. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.5.1. USA |
9.5.2. Canada |
10. Europe Artificial Iris Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Fiber |
10.1.2. Fiber Free |
10.2. Age Group Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Pediatric |
10.2.2. Adult |
10.3. Application Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Therapeutic |
10.3.2. Cosmetic |
10.4. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1. Public Hospitals |
10.4.2. Private Hospitals |
10.5. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1. Germany |
10.5.2. France |
10.5.3. Italy |
10.5.4. Spain |
10.5.5. Rest of Europe |
11. RoW Artificial Iris Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Fiber |
11.1.2. Fiber Free |
11.2. Age Group Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Pediatric |
11.2.2. Adult |
11.3. Application Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Therapeutic |
11.3.2. Cosmetic |
11.4. End-user Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Public Hospitals |
11.4.2. Private Hospitals |
11.5. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1. China |
11.5.2. Japan |
11.5.3. Brazil |
11.5.4. Rest of World |
12. Competition Landscape |
12.1. Strategic Dashboard of Top Market Players |
12.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
12.2.1. Ophtec |
12.2.2. HumanOptics AG |
12.2.3. Morcher GmbH |
12.2.4. Brightocular |
13. Research Methodology |
14. Key Assumptions and Acronyms |
Key Market Players